Användarvänlighet och klinisk effektivitet i systemet NEVERMIND Usability and Clinical effectiveness of the NEVERMIND system 2023-106-1-1 https://doi.org/10.48723/21y0-2g17 Swedish National Data Service Svensk nationell datatjänst Landing page Användarvänlighet och klinisk effektivitet i systemet NEVERMIND Usability and Clinical effectiveness of the NEVERMIND system 2023-106-1-1 https://doi.org/10.48723/21y0-2g17 oai:prod.swepub.kib.ki.se:235675116 10.2196/33734 oai:prod.swepub.kib.ki.se:150119517 10.1016/j.eclinm.2022.101423 10.1186/s12888-020-02494-3 Petros, Nuhamin Gebrewold Petros, Nuhamin Gebrewold Swedish National Data Service Svensk nationell datatjänst Landing page Mental Health Psykisk hälsa The data provided is from the NEVERMIND trial, a randomized controlled trial to assess the effectiveness of the NEVERMIND system in reducing depressive symptoms among individuals with severe somatic conditions. The dataset includes data on 255 patients diagnosed with breast cancer or prostate cancer who were randomly assigned to the NEVERMIND intervention or a control group. The data includes baseline sociodemographic data, structured questionnaires on mental health symptoms (Beck Depression Inventory-II and Depression, Anxiety and Stress Scale-21), acceptability and usability (System Usability Scale, user version of the Mobile Application Rating Scale, Perceived usefulness and Perceived ease of use) and recorded log data collected at 12 weeks to assess the effectiveness, usability, and acceptability of the NEVERMIND system. The NEVERMIND system consists of a shirt and a smart phone. Sensors in the shirt and an application in the smart phone data collect data on the patient's condition. The main purpose of the dataset is to investigate the relationship between the clinical effectiveness, usability, and acceptability of the NEVERMIND eHealth intervention for treating depressive and stress symptoms in breast and prostate cancer patients. Linear mixed model analyses and multiple regression were used to evaluate the association between clinical effectiveness, usability, and acceptability variables. The dataset is relevant for reuse by researchers interested in investigating the effectiveness of eHealth interventions for treating depressive and stress symptoms in cancer patients. The dataset consists of a file called dataset_usability_clinical_nevermind.xlsx, which contains a table with data collected from individuals in the study. A codebook file (Codebook.xlsx) is also included and defines the variables used in the table. Den tillhandahållna datan kommer från NEVERMIND-testet, en randomiserad kontrollerad studie för att utvärdera effektiviteten av NEVERMIND-systemet för att minska depressiva symtom hos personer med svåra somatiska tillstånd. Datasetet inkluderar data från 255 patienter som diagnostiserats med bröstcancer eller prostatacancer som slumpades till antingen NEVERMIND-interventionen eller en kontrollgrupp. Datasetet inkluderar sociodemografisk data vid baseline, strukturerade enkäter om psykisk hälsa (Beck Depression Inventory-II och Depression, Anxiety and Stress Scale-21), acceptabilitet och användbarhet (System Usability Scale, användarversionen av Mobile Application Rating Scale, upplevd nytta och upplevd användarvänlighet) och registrerade loggdata insamlade vid 12 veckors uppföljning för att bedöma effektiviteten, användbarheten och acceptabiliteten för NEVERMIND-systemet. NEVERMIND-systemet består av både en tröja och en mobiltelefon utrustade med ”smartphoneteknologi”. Med hjälp av sensorer i tröjan och en applikation på mobiltelefonen samlas data in om patienternas tillstånd. Huvudsyftet med datasetet är att undersöka sambandet mellan den kliniska effektiviteten, användbarheten och acceptabiliteten av NEVERMIND eHälsoingripandet för att behandla depressiva och stressymtom hos bröst- och prostatacancerpatienter. Linjär blandad modellanalys och multipel regression användes för att utvärdera sambandet mellan klinisk effektivitet, användbarhet och acceptabilitetsvariabler. Datasetet är relevant för återanvändning av forskare som är intresserade av att undersöka effektiviteten av eHälsoingripanden för att behandla depressiva och stressymtom hos cancerpatienter. Datasetet består av en fil (dataset_usability_clinical_nevermind.xlsx) som innehåller en tabell med data samlade från deltagarna i studien samt en fil (Codebook.xlsx) som innehåller en lista över variablerna med förklarande text. Italy Italien IndividualIndividual IndividIndivid 255 patients diagnosed either with stage II, III, or IV breast or prostate cancer were randomly assigned to the NEVERMIND intervention or a control group. 255 patienter som diagnostiserats med bröstcancer eller prostatacancer i stadium II, III eller IV slumpades till antingen NEVERMIND-interventionen eller en kontrollgrupp. Numeric Cross-sectionCross-section TvärsnittTvärsnitt LongitudinalLongitudinal LongitudinellLongitudinell Breast and prostate cancer patients were recruited from the Piedmont Oncological Network, at San Luigi Gonzaga University Hospital, Turin, Italy and Breast Unit-Oncology Department and Urology Department at Città della Salute e della Scienza University Hospital, Turin, Italy. The departments are the main departments for the region, thus, patients come from all over the region to the clinical centres.Breast and prostate cancer patients were recruited from the Piedmont Oncological Network, at San Luigi Gonzaga University Hospital, Turin, Italy and Breast Unit-Oncology Department and Urology Department at Città della Salute e della Scienza University Hospital, Turin, Italy. The departments are the main departments for the region, thus, patients come from all over the region to the clinical centres. Bröst- och prostatacancerpatienter rekryterades från Piedmont Oncological Network vid San Luigi Gonzaga University Hospital, Turin, Italien och Breast Unit-Oncology Department och Urology Department vid Città della Salute e della Scienza University Hospital, Turin, Italien.Bröst- och prostatacancerpatienter rekryterades från Piedmont Oncological Network vid San Luigi Gonzaga University Hospital, Turin, Italien och Breast Unit-Oncology Department och Urology Department vid Città della Salute e della Scienza University Hospital, Turin, Italien. Access to data through SND. Access to data is restricted. Åtkomst till data via SND. Tillgång till data är begränsad. restrictedAccess Petros, N., Hadlaczky, G., Carletto, S., Martinez, S., Ostacoli, L., Ottaviano, M., Meyer, B., Scilingo, E., & Carli, V. (n.d.). Sociodemographic Characteristics Associated With an eHealth System Designed to Reduce Depressive Symptoms Among Patients With Breast or Prostate Cancer: Prospective Study. In JMIR formative research (Vol. 6, Issue 6, pp. e33734-). https://doi.org/10.2196/33734 Petros, N., Hadlaczky, G., Carletto, S., Martinez, S., Ostacoli, L., Ottaviano, M., Meyer, B., Scilingo, E., & Carli, V. (n.d.). Sociodemographic Characteristics Associated With an eHealth System Designed to Reduce Depressive Symptoms Among Patients With Breast or Prostate Cancer: Prospective Study. In JMIR formative research (Vol. 6, Issue 6, pp. e33734-). https://doi.org/10.2196/33734 10.2196/33734 oai:prod.swepub.kib.ki.se:235675116 2022 oai:prod.swepub.kib.ki.se:235675116 Carli, V., Petros, N., Hadlaczky, G., Vitcheva, T., Berchialla, P., Bianchi, S., Carletto, S., Christinaki, E., Citi, L., Dinis, S., Gentili, C., Geraldes, V., Giovinazzo, L., Gonzalez-Martinez, S., Meyer, B., Ostacoli, L., Ottaviano, M., Ouakinin, S., Papastylianou, T., … Valenza, G. (2022). The NEVERMIND e-health system in the treatment of depressive symptoms among patients with severe somatic conditions: A multicentre, pragmatic randomised controlled trial. In EClinicalMedicine (Vol. 48, pp. 101423-). https://doi.org/10.1016/j.eclinm.2022.101423 Carli, V., Petros, N., Hadlaczky, G., Vitcheva, T., Berchialla, P., Bianchi, S., Carletto, S., Christinaki, E., Citi, L., Dinis, S., Gentili, C., Geraldes, V., Giovinazzo, L., Gonzalez-Martinez, S., Meyer, B., Ostacoli, L., Ottaviano, M., Ouakinin, S., Papastylianou, T., … Valenza, G. (2022). The NEVERMIND e-health system in the treatment of depressive symptoms among patients with severe somatic conditions: A multicentre, pragmatic randomised controlled trial. In EClinicalMedicine (Vol. 48, pp. 101423-). https://doi.org/10.1016/j.eclinm.2022.101423 10.1016/j.eclinm.2022.101423 oai:prod.swepub.kib.ki.se:150119517 2022 oai:prod.swepub.kib.ki.se:150119517 Carli, V., Wasserman, D., Hadlaczky, G., Petros, N. G., Carletto, S., Citi, L., ... & Scilingo, E. P. (2020). A protocol for a multicentre, parallel-group, pragmatic randomised controlled trial to evaluate the NEVERMIND system in preventing and treating depression in patients with severe somatic conditions. BMC psychiatry, 20(1), 1-10. Carli, V., Wasserman, D., Hadlaczky, G., Petros, N. G., Carletto, S., Citi, L., ... & Scilingo, E. P. (2020). A protocol for a multicentre, parallel-group, pragmatic randomised controlled trial to evaluate the NEVERMIND system in preventing and treating depression in patients with severe somatic conditions. BMC psychiatry, 20(1), 1-10. 10.1186/s12888-020-02494-3 2020